Biotechnology Ultrasector Profund Fund Technical Analysis

BIPIX Fund  USD 67.49  0.29  0.43%   
As of the 14th of February 2026, Biotechnology Ultrasector shows the Mean Deviation of 1.94, downside deviation of 2.38, and Risk Adjusted Performance of 0.0912. Biotechnology Ultrasector technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the entity's future prices.

Biotechnology Ultrasector Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Biotechnology, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Biotechnology
  
Biotechnology Ultrasector's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
It's important to distinguish between Biotechnology Ultrasector's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biotechnology Ultrasector should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Biotechnology Ultrasector's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biotechnology Ultrasector 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biotechnology Ultrasector's mutual fund what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biotechnology Ultrasector.
0.00
11/16/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/14/2026
0.00
If you would invest  0.00  in Biotechnology Ultrasector on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Biotechnology Ultrasector Profund or generate 0.0% return on investment in Biotechnology Ultrasector over 90 days. Biotechnology Ultrasector is related to or competes with Internet Ultrasector, Columbia Adaptive, Biotechnology Ultrasector, Royce Small-cap, Ashmore Emerging, Ashmore Emerging, and Neuberger Berman. The index is designed to measure the performance of biotechnology companies included in the SP Total Market Index More

Biotechnology Ultrasector Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biotechnology Ultrasector's mutual fund current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biotechnology Ultrasector Profund upside and downside potential and time the market with a certain degree of confidence.

Biotechnology Ultrasector Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotechnology Ultrasector's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biotechnology Ultrasector's standard deviation. In reality, there are many statistical measures that can use Biotechnology Ultrasector historical prices to predict the future Biotechnology Ultrasector's volatility.
Hype
Prediction
LowEstimatedHigh
65.0067.4969.98
Details
Intrinsic
Valuation
LowRealHigh
65.1067.5970.08
Details

Biotechnology Ultrasector February 14, 2026 Technical Indicators

Biotechnology Ultrasector Backtested Returns

At this stage we consider Biotechnology Mutual Fund to be very steady. Biotechnology Ultrasector secures Sharpe Ratio (or Efficiency) of 0.0733, which signifies that the fund had a 0.0733 % return per unit of risk over the last 3 months. We have found twenty-six technical indicators for Biotechnology Ultrasector Profund, which you can use to evaluate the volatility of the entity. Please confirm Biotechnology Ultrasector's Downside Deviation of 2.38, mean deviation of 1.94, and Risk Adjusted Performance of 0.0912 to double-check if the risk estimate we provide is consistent with the expected return of 0.18%. The fund shows a Beta (market volatility) of 1.23, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biotechnology Ultrasector will likely underperform.

Auto-correlation

    
  0.35  

Below average predictability

Biotechnology Ultrasector Profund has below average predictability. Overlapping area represents the amount of predictability between Biotechnology Ultrasector time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biotechnology Ultrasector price movement. The serial correlation of 0.35 indicates that nearly 35.0% of current Biotechnology Ultrasector price fluctuation can be explain by its past prices.
Correlation Coefficient0.35
Spearman Rank Test0.22
Residual Average0.0
Price Variance4.17
Biotechnology Ultrasector technical mutual fund analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, fund market cycles, or different charting patterns.
A focus of Biotechnology Ultrasector technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Biotechnology Ultrasector trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Biotechnology Ultrasector Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Biotechnology Ultrasector across different markets.

About Biotechnology Ultrasector Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Biotechnology Ultrasector Profund on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Biotechnology Ultrasector Profund based on its technical analysis. In general, a bottom-up approach, as applied to this mutual fund, focuses on Biotechnology Ultrasector price pattern first instead of the macroeconomic environment surrounding Biotechnology Ultrasector. By analyzing Biotechnology Ultrasector's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Biotechnology Ultrasector's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Biotechnology Ultrasector specific price patterns or momentum indicators. Please read more on our technical analysis page.

Biotechnology Ultrasector February 14, 2026 Technical Indicators

Most technical analysis of Biotechnology help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biotechnology from various momentum indicators to cycle indicators. When you analyze Biotechnology charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Biotechnology Ultrasector One Year Return

Based on the recorded statements, Biotechnology Ultrasector Profund has an One Year Return of 55%. This is 6.78% higher than that of the ProFunds family and about the same as Trading--Leveraged Equity (which currently averages 56.23) category. The one year return for all United States funds is notably lower than that of the firm.
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.

Biotechnology Ultrasector February 14, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Biotechnology stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Other Information on Investing in Biotechnology Mutual Fund

Biotechnology Ultrasector financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Ultrasector security.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules